Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities.
Saved in:
| Title: | Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities. |
|---|---|
| Authors: | Podder V; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida., Coleman RL; Gynecologic Oncology, Texas Oncology, The Woodlands, Texas., Hagemann AR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, Alvin J. Siteman Cancer Center, St. Louis, Missouri., Singhania P; Department of General Surgery, Shaheed Ziaur Rahman Medical College, Bogra, Bangladesh., Powell MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, Alvin J. Siteman Cancer Center, St. Louis, Missouri., Herzog TJ; Division of Gynecologic Oncology, University of Cincinnati, Cincinnati, Ohio., Slomovitz BM; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Feb 04; Vol. 32 (3), pp. 447-454. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
